gvtcx

PHE_Scientific- Purchase of CTL Biospot Analyser

Public Health England Published 3 Mar 2021 Contracts Finder

key details

Value£78,421
Statuscomplete
Category (CPV) 38434000
Deadline12 Mar 2021
Contract start15 Mar 2021
Contract end14 Mar 2022
Procedurelimited
SME suitableNo
OCIDocds-b5fd17-3f034e81-16fd-4ce1-9422-2dd13d0a2b00

Award

SupplierValueDateStatus
not named £78,421 15 Mar 2021 active

description

The UK Government must protect the health and wellbeing of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 January 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 March 2020.

Public Health England (PHE) discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health and Social Care within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the recent COVID -19 outbreak.

A direct award has been made due to Cellular Technologies Limited (CTL) Europe GmbH extreme urgency under current public procurement regulations using regulation 32(2)(c) for the provision Biospot Analyser, to increase capacity and ensure continuity of service.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
3 Mar 2021 Award (award) · e1d1abd2-b828-4a17-8fb3-3b552046743e-417302

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.